Author:
Sorenson Corinna,Chalkidou Kalipso
Abstract
AbstractHealth technology assessment (HTA) has assumed an increasing role in health systems in recent years, with many countries establishing agencies or programmes to evaluate health technology and other interventions to inform policy decisions and clinical practice. This paper reflects upon its development and evolution in Europe over the last decade, with a focus on England, France, Germany and Sweden. In particular, we explore how HTA has evolved over time as well as its impact on policy and practice. While countries share many of the same objectives, there are differences in the way HTA agencies and programmes are organised, operate, and influence decision making. Despite these differences, all systems are faced with opportunities and challenges related to stakeholder involvement and acceptance, the suitability and transparency of assessment requirements and methods, balancing evidence and values in decision making, and demonstrating impact.
Publisher
Cambridge University Press (CUP)
Reference72 articles.
1. National Institute for Clinical Excellence and its value judgments
2. WHO evaluates NICE
3. Patel P. , Roberts S. , Sparrowhawk K. , Ng Haing J. (2010), ‘Evaluating comparative effectiveness research for oncology in the US: An analysis based on lessons from health technology assessment in Europe’, ISPOR 15th Annual International Meeting, May 15–19th, Atlanta, GA.
Cited by
48 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献